Pfizer's stock returned higher in the intraday levels, amid the complete dominance of the main upward trend in the medium and short terms, with positive pressure from the 50-day SMA, readying thereafter to tackle the resistance of 42.77, with the stock scoring a 1.16% profit in the last session, or 0.48 points, with negative signals from the Relative Strength Index after reaching overbought levels.
Therefore we expect more gains for the stock, especially if the resistance of 42.77 was breached, targeting the next one at 45.26.
Expected trend for today: Bullish